[PHARMA] QoQ TTM Result on 30-Jun-2012 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 2.74%
YoY- 87.92%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 1,865,940 1,812,346 1,697,728 1,642,700 1,582,398 1,520,981 1,529,311 14.16%
PBT 97,283 103,314 115,434 102,587 94,349 73,186 54,117 47.79%
Tax -37,985 -40,108 -32,578 -34,308 -28,102 -20,401 -15,466 81.93%
NP 59,298 63,206 82,856 68,279 66,247 52,785 38,651 32.98%
-
NP to SH 57,797 61,711 81,587 67,151 65,358 52,157 37,959 32.31%
-
Tax Rate 39.05% 38.82% 28.22% 33.44% 29.79% 27.88% 28.58% -
Total Cost 1,806,642 1,749,140 1,614,872 1,574,421 1,516,151 1,468,196 1,490,660 13.66%
-
Net Worth 484,829 472,037 496,469 481,394 474,161 514,153 464,092 2.95%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Div 41,189 41,188 64,713 52,948 44,120 35,296 - -
Div Payout % 71.27% 66.74% 79.32% 78.85% 67.51% 67.67% - -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Net Worth 484,829 472,037 496,469 481,394 474,161 514,153 464,092 2.95%
NOSH 117,676 117,715 117,646 117,700 117,657 117,655 106,933 6.58%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin 3.18% 3.49% 4.88% 4.16% 4.19% 3.47% 2.53% -
ROE 11.92% 13.07% 16.43% 13.95% 13.78% 10.14% 8.18% -
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 1,585.65 1,539.60 1,443.07 1,395.66 1,344.91 1,292.74 1,430.15 7.11%
EPS 49.11 52.42 69.35 57.05 55.55 44.33 35.50 24.12%
DPS 35.00 35.00 55.00 44.99 37.50 30.00 0.00 -
NAPS 4.12 4.01 4.22 4.09 4.03 4.37 4.34 -3.40%
Adjusted Per Share Value based on latest NOSH - 117,700
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 129.47 125.75 117.80 113.98 109.79 105.53 106.11 14.17%
EPS 4.01 4.28 5.66 4.66 4.53 3.62 2.63 32.43%
DPS 2.86 2.86 4.49 3.67 3.06 2.45 0.00 -
NAPS 0.3364 0.3275 0.3445 0.334 0.329 0.3567 0.322 2.95%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 -
Price 8.26 8.10 7.55 10.18 5.90 5.36 5.90 -
P/RPS 0.52 0.53 0.52 0.73 0.44 0.41 0.41 17.15%
P/EPS 16.82 15.45 10.89 17.84 10.62 12.09 16.62 0.79%
EY 5.95 6.47 9.19 5.60 9.42 8.27 6.02 -0.77%
DY 4.24 4.32 7.28 4.42 6.36 5.60 0.00 -
P/NAPS 2.00 2.02 1.79 2.49 1.46 1.23 1.36 29.28%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 -
Price 9.26 7.80 8.25 8.83 5.90 5.90 5.90 -
P/RPS 0.58 0.51 0.57 0.63 0.44 0.46 0.41 25.99%
P/EPS 18.85 14.88 11.90 15.48 10.62 13.31 16.62 8.74%
EY 5.30 6.72 8.41 6.46 9.42 7.51 6.02 -8.13%
DY 3.78 4.49 6.67 5.09 6.36 5.08 0.00 -
P/NAPS 2.25 1.95 1.95 2.16 1.46 1.35 1.36 39.83%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment